Evans, Mark J <br/><br/>
A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.  [electronic resource] 

 -  American journal of physiology. Gastrointestinal and liver physiology  Mar 2009 
 - G543-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0193-1857 
<br/><br/><label>Standard No.: </label>10.1152/ajpgi.90585.2008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apolipoprotein A-I--blood<br/>Azepines--chemistry<br/>Cells, Cultured<br/>Cholesterol--blood<br/>DNA-Binding Proteins--agonists<br/>Disease Models, Animal<br/>Dyslipidemias--complications<br/>Female<br/>Fructose--pharmacology<br/>Humans<br/>Hyperglycemia--complications<br/>Hyperinsulinism--complications<br/>Indoles--chemistry<br/>Kidney--cytology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Mutant Strains<br/>Mice, Transgenic<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Receptors, LDL--genetics<br/>Receptors, Leptin--genetics<br/>Transcription Factors--agonists<br/>Triglycerides--blood